logo
Plus   Neg
Share
Email

Teva Launches Autoinjector For AJOVY Injection In U.S.

Teva Pharmaceutical Industries Ltd. (TEVA) said Monday that the autoinjector device for AJOVY or fremanezumab-vfrm injection is now available in the U.S. The list price for the AJOVY autoinjector is $603.20.

In addition to the U.S., the AJOVY autoinjector is currently available in Germany and should soon be available in other select European markets.

AJOVY is indicated for the preventive treatment of migraine in adults and is the only anti-CGRP or calcitonin gene-related peptide preventive migraine treatment with quarterly (675 mg) and monthly (225 mg) subcutaneous dosing options.

The company noted that the autoinjector also has several features that make it easy-to-use including a button-free, push-down mechanism; audible cues that signal progress of administration; and, a window that displays when the dose has been delivered. Additionally, the autoinjector is for one-time use only and locks after use.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter could face a fine of up to $250 million from the U.S. Federal Trade Commission regarding its use of phone numbers and email addresses to target advertisements. Lord & Taylor joined the growing list of U.S. retailers who filed for bankruptcy amid the coronavirus pandemic. Lord & Taylor, one of the oldest department store chains in the U.S., filed for bankruptcy protection in the Eastern Court of Virginia on Sunday. The company operated 38 stores that have remained temporarily closed since March this year due to the pandemic. Thomson International Inc. is recalling Red, Yellow, White, and Sweet Yellow Onions for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The onions are in distribution since May 1, 2020. They were sold to wholesalers, restaurants, and retail stores in all 50 U.S. states, the District of Columbia and Canada.
Follow RTT